WP
Woodline Partners Portfolio holdings
AUM
$25.8B
1-Year Est. Return
36.53%
This Fund
S&P 500
1 Year Est. Return
+36.53%
AUM
$25.8B
AUM Growth
+$4.56B
(+21%)
Holding
1,157
Top Buys
| 1 | +$997M | |
| 2 | +$215M | |
| 3 | +$209M | |
| 4 |
Verizon
VZ
|
+$208M |
| 5 |
Amphenol
APH
|
+$143M |
Top Sells
| 1 | +$200M | |
| 2 | +$158M | |
| 3 | +$141M | |
| 4 |
Chubb
CB
|
+$115M |
| 5 |
argenx
ARGX
|
+$106M |
Sector Composition
| 1 | Healthcare | 24.16% |
| 2 | Technology | 23.32% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMPD
1151
Empery Digital
EMPD
$152M
| – | – |
-843,767
|
|
||
1152
Vor Biopharma
VOR
$741M
| – | – |
-27,363
|
|
||
1153
Voya Financial
VOYA
$6.92B
| – | – |
-1,191,884
|
|
||
|
VRNA
1154
DELISTED
Verona Pharma
VRNA
| – | – |
-317,587
|
|
||
|
VRNT
1155
DELISTED
Verint Systems
VRNT
| – | – |
-1,150,001
|
|
||
1156
Verastem
VSTM
$531M
| – | – |
-307,554
|
|
||
|
VTYX
1157
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-45,826
|
|